Apple tightens rules for medical apps in the App Store

Apple is expanding the requirements for app developers in the health and medical sector. Going forward, the App Store must clearly indicate whether an application is classified as a regulated medical device. This regulation applies to the European Economic Area (EEA), the United Kingdom, and the United States, and changes both the App Store display and the obligations for developers.

Health apps are increasingly taking over tasks that were previously the sole domain of medical professionals. They assist with diagnosis, monitor vital signs, and support therapies. This development also increases the need for clear regulatory frameworks.

Apple is responding with a structured labeling requirement. The goal is to make it clear which apps are medically regulated and which are not. At the same time, developers are required to document their applications more transparently and classify them according to regulatory standards.

App Store label

Apple has announced that App Store product pages will now indicate whether an app is a regulated medical device. This label will be visible uniformly in the following regions:

European Economic Area (EEA)
United Kingdom
United States

This makes the medical status of an app directly visible to users.

Definition of regulated medical devices

According to Apple, apps are considered regulated medical devices when used for medical purposes. This includes applications that:

Diagnosing diseases
prevent health problems
monitor physiological conditions
support or carry out treatments

These apps can either function independently or be part of a broader medical system.

Involvement of supervisory authorities

A key component of the new regulation is its link to regulatory requirements. Apps classified as medical devices may require registration or approval by relevant authorities, including the Food and Drug Administration in the USA.

Similar regulatory requirements apply in Europe and the United Kingdom, and these must be adhered to.

Mandatory information in the App Store

For apps classified as regulated medical devices, additional information is displayed in the App Store. This includes:

EU Manufacturer SRN or FDA Operator Number
a URL with instructions
detailed instructions for use
Security information

This information is intended to make the app safer to use and to facilitate its classification.

New obligations for developers

Developers offering health, fitness, or medical apps in the EEA, the UK, or the US must indicate their app's status in App Store Connect. Additionally, the relevant regulatory information is required.

The obligation also applies to apps that are classified in the age rating questionnaire as applications with frequent references to medical or treatment-related content.

Schedule and deadlines

Apple has defined clear guidelines for implementation:

From now on: New apps must indicate their status as a regulated medical device if they meet the criteria.
By early 2027: Existing apps must retroactively update their status.

Those who do not meet these requirements must expect restrictions. Developers who do not specify a status by the beginning of 2027 will no longer be able to submit updates for their apps.

Further information

Apple refers to its own developer website for detailed specifications and technical implementation. Further information on labeling and regulatory requirements is available there.

Apple's new rules bring clarity for medical apps

Apple's new labeling requirement brings more structure to the handling of medical apps in the App Store. The medical status is displayed transparently, while developers are held more accountable.

The combination of clear criteria, mandatory information, and fixed deadlines demonstrates Apple's consistent regulation of the healthcare sector. For developers, this means a stronger focus on legal requirements and a more precise classification of their applications within a medical context. (Image: SashaMagic / DepositPhotos.com)